BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CEACAM5, CEA AND Diagnosis
263 results:

  • 1. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
    Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
    Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Ultrasonographic features of thyroid carcinoma of different sizes: comparison between medullary thyroid carcinomas and papillary thyroid carcinomas].
    Zhang D; Yang F; Wang Y; Mu JL; Wei XQ; Wei X
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):133-139. PubMed ID: 38418187
    [No Abstract]    [Full Text] [Related]  

  • 3. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
    Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
    Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
    Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
    BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnostic value of CT and MRI combined with serum LDH, NSE, cea, and MYCN in pediatric neuroblastoma.
    Hao J; Sang J; Xu X; Bao A
    World J Surg Oncol; 2023 Aug; 21(1):251. PubMed ID: 37592273
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.
    Xiao Z; Xu H; Strosberg JR; Lu R; Zhu X; Deng S; Ding L; Ni Q; Warshaw AL; Yu X; Luo G
    Int J Cancer; 2023 Jul; 153(1):164-172. PubMed ID: 36891979
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ovarian strumal carcinoid: a case report.
    Kanasugi M; Nishiyama H; Sanpei M; Asano S; Honda T
    Fukushima J Med Sci; 2023 Apr; 69(1):51-55. PubMed ID: 36878591
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Hereditary medullary thyroid cancer].
    Fendrich V; Zahn A
    Chirurgie (Heidelb); 2023 May; 94(5):393-399. PubMed ID: 36799965
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinicopathological analysis of superior mediastinal lymph node metastases in medullary thyroid carcinoma].
    He YY; Chen YT; Wang J; Chen MQ; Zhu YM; Ni S; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):82-87. PubMed ID: 36709124
    [No Abstract]    [Full Text] [Related]  

  • 10. Other markers of medullary thyroid cancer, not only calcitonin.
    Censi S; Manso J; Mian C
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. diagnosis of a cystic pancreatic neuroendocrine tumor: is cystic fluid chromogranin A useful?
    Marín Serrano E; Duque Alcorta M
    Rev Esp Enferm Dig; 2023 Sep; 115(9):526-527. PubMed ID: 36454060
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ductal differentiation: A rare phenomenon in Merkel cell carcinoma.
    Vanderbeck K; Cho WC; Aung PP; Ivan D; Rothrock AT; Torres-Cabala CA; Prieto VG; Curry JL; Nagarajan P
    J Cutan Pathol; 2023 Jun; 50(6):511-519. PubMed ID: 36454019
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: diagnosis, Treatment, and Follow-Up Strategy.
    Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
    Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
    Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
    Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Medullary thyroid carcinoma diagnosed with liquid-based cytology and immunocytochemistry.
    Nikas IP; Kazamias G; Vrontaki M; Rapti AS; Mastorakis E
    J Immunoassay Immunochem; 2022 Sep; 43(5):502-515. PubMed ID: 35475413
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. "Incidentally discovered medullary thyroid carcinoma in the post-operative Graves' patient - A case report".
    Akin R; Gilley D; Tassone P
    Am J Otolaryngol; 2022; 43(3):103450. PubMed ID: 35429846
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Pajak C; Cadili L; Nabata K; Wiseman SM
    Am J Surg; 2022 Aug; 224(2):670-675. PubMed ID: 35382933
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
    Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Well-Differentiated Grade-3 Neuroendocrine tumor in the Ascending Colon: A Case Report.
    AlSaffar A; Wood S; AlRabiy F; Hamie D; Termos S
    Am J Case Rep; 2022 Jan; 23():e933792. PubMed ID: 35013091
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Application of serum markers in medullary thyroid carcinoma].
    Han XD; Lu RQ; Hu HY; Guo L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1468-1474. PubMed ID: 34963245
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 14.